“as well as evaluating the feasibility and timel
Post# of 148230
(Total Views: 468)
Posted On: 08/23/2023 10:15:03 AM
Re: biloxiblues #136764
“as well as evaluating the feasibility and timelines for the HIV BLA resubmission and explore other cancer and immunologic indications for leronlimab.”
Why is this still mentioned? Do we really think we can submit the BLA. This would be even better news then a partnership or even any buyout imo. But does anyone honestly believe this is even possible?
Ohm If you don’t mind commenting I’d appreciate your opinion or anyone else for that matter.
Why is this still mentioned? Do we really think we can submit the BLA. This would be even better news then a partnership or even any buyout imo. But does anyone honestly believe this is even possible?
Ohm If you don’t mind commenting I’d appreciate your opinion or anyone else for that matter.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼